The synapse has consistently been considered a vulnerable and critical target within
Alzheimer's disease, and synapse loss is, to date, one of the main biological correlates of …

Alzheimer's disease (AD) is characterized by reduced fast brain oscillations in the gamma
band (γ,> 30 Hz). Several animal studies show that inducing gamma oscillations through …

Patients with cancer undergoing chemotherapy frequently experience a neurological
condition known as chemotherapy-related cognitive impairment, or “chemobrain,” which can …

Flickering light stimulation has emerged as a promising non-invasive neuromodulation
strategy to alleviate neuropsychiatric disorders. However, the lack of a neurochemical …

The last decades have witnessed huge efforts devoted to deciphering the pathological
mechanisms underlying Alzheimer's Disease (AD) and to testing new drugs, with the recent …

The most prevalent cause of dementia is Alzheimer's disease. Cognitive decline and
accelerating memory loss characterize it. Alzheimer's disease advances sequentially …

Evoked brain oscillations in the gamma range have been shown to assist in stroke recovery.
However, the causal relationship between evoked oscillations and neuroprotection is not …

Alzheimer's disease (AD) is the most prevalent dementia, pathologically featuring abnormal
accumulation of amyloid-β (A β) and hyperphosphorylated tau, while sleep, divided into …

Understanding the neural basis of cognitive deficits, a key feature of Alzheimer's disease
(AD), is imperative for achieving the therapy of the disease. Rhythmic oscillatory activities in …

Cognitive function is an important ability of the brain, but cognitive dysfunction can easily
develop once the brain is injured in various neuropathological conditions or diseases …